The Europe Cold And Flu Supplements Market should witness market growth of 11.7% CAGR during the forecast period (2023-2030).
Customers are expected to spend more on cold and flu supplements as their purchasing power grows. These supplements are becoming more popular among customers to increase immunity and stop the spread of infections. The market is expanding due to the rising government support for providing free flu vaccinations.
The increased accessibility of supplements through offline & online stores and changing lifestyles have fuelled the need for cold and flu supplements. The market is also driven by consumers' growing awareness of the medicinal advantages of numerous natural ingredients. Additionally, increased consumer spending on other immune health products, like cold and flu supplements, is predicted to rise. Customers have been requesting additional cold and flu vitamins to boost immunity and prevent the spread of these ailments. Increasing one's immune system is the primary goal of these supplements. A strong pace of market growth is also projected as consumers become more aware of the benefits of using these supplements.
Natural and herbal supplements are becoming more popular among consumers since they are thought to have immunity-boosting benefits without the adverse side effects of conventional drugs. Consumers now have easy access to various cold and flu supplements and may choose their products with knowledge, due to the spread of online shopping platforms.
Research from the U.K. government titled "Future of an aging population" predicts that by 2040, one in seven individuals in the U.K. will be over 75. Due to the increasing risk of illnesses like AMD, glaucoma, and others due to this demographic trend, there is a growing interest in preventive methods for maintaining eye health, which has boosted this market. Because older people typically have poor immune systems and are advised to take preventive steps in advance to strengthen their immune systems, it is expected that the aging populations in European countries would present growth opportunities for market participants.
The Germany market dominated the Europe Cold And Flu Supplements Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,429.3 million by 2029. The UK market is estimated to witness a CAGR of 10.8% during (2023-2030). Additionally, The France market would showcase a CAGR of 12.5% during (2023-2030).
Based on Product, the market is segmented into Vitamins & Minerals, Herbal Extracts, and Natural Molecules. Based on Distribution Channel, the market is segmented into Pharmacies & Drug Stores, Hypermarkets & Supermarkets, Online, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Nordic Naturals, Inc., Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer, Inc., Amway Corporation, NOW Foods, Inc., Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.), Neurobiologix, Inc., Himalaya Global Holdings Ltd., Nu Skin Enterprises, Inc., and Nature’s Sunshine Products, Inc.
Customers are expected to spend more on cold and flu supplements as their purchasing power grows. These supplements are becoming more popular among customers to increase immunity and stop the spread of infections. The market is expanding due to the rising government support for providing free flu vaccinations.
The increased accessibility of supplements through offline & online stores and changing lifestyles have fuelled the need for cold and flu supplements. The market is also driven by consumers' growing awareness of the medicinal advantages of numerous natural ingredients. Additionally, increased consumer spending on other immune health products, like cold and flu supplements, is predicted to rise. Customers have been requesting additional cold and flu vitamins to boost immunity and prevent the spread of these ailments. Increasing one's immune system is the primary goal of these supplements. A strong pace of market growth is also projected as consumers become more aware of the benefits of using these supplements.
Natural and herbal supplements are becoming more popular among consumers since they are thought to have immunity-boosting benefits without the adverse side effects of conventional drugs. Consumers now have easy access to various cold and flu supplements and may choose their products with knowledge, due to the spread of online shopping platforms.
Research from the U.K. government titled "Future of an aging population" predicts that by 2040, one in seven individuals in the U.K. will be over 75. Due to the increasing risk of illnesses like AMD, glaucoma, and others due to this demographic trend, there is a growing interest in preventive methods for maintaining eye health, which has boosted this market. Because older people typically have poor immune systems and are advised to take preventive steps in advance to strengthen their immune systems, it is expected that the aging populations in European countries would present growth opportunities for market participants.
The Germany market dominated the Europe Cold And Flu Supplements Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,429.3 million by 2029. The UK market is estimated to witness a CAGR of 10.8% during (2023-2030). Additionally, The France market would showcase a CAGR of 12.5% during (2023-2030).
Based on Product, the market is segmented into Vitamins & Minerals, Herbal Extracts, and Natural Molecules. Based on Distribution Channel, the market is segmented into Pharmacies & Drug Stores, Hypermarkets & Supermarkets, Online, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Nordic Naturals, Inc., Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer, Inc., Amway Corporation, NOW Foods, Inc., Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.), Neurobiologix, Inc., Himalaya Global Holdings Ltd., Nu Skin Enterprises, Inc., and Nature’s Sunshine Products, Inc.
Scope of the Study
By Product
- Vitamins & Minerals
- Herbal Extracts
- Natural Molecules
By Distribution Channel
- Pharmacies & Drug Stores
- Hypermarkets & Supermarkets
- Online
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Nordic Naturals, Inc.
- Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
- Pfizer, Inc.
- Amway Corporation
- NOW Foods, Inc.
- Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
- Neurobiologix, Inc.
- Himalaya Global Holdings Ltd.
- Nu Skin Enterprises, Inc.
- Nature’s Sunshine Products, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Cold And Flu Supplements Market by Product
Chapter 5. Europe Cold And Flu Supplements Market by Distribution Channel
Chapter 6. Europe Cold And Flu Supplements Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Nordic Naturals, Inc.
- Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
- Pfizer, Inc.
- Amway Corporation
- NOW Foods, Inc.
- Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
- Neurobiologix, Inc.
- Himalaya Global Holdings Ltd.
- Nu Skin Enterprises, Inc.
- Nature’s Sunshine Products, Inc.
Methodology
LOADING...
